
About Armn Pharmaceutical India Private Limited
Data last updated:
Armn Pharmaceutical India Private Limited is a private limited company based in Panipat, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2019PTC083268. Its GSTIN is 06AASCA8715D2ZJ (Haryana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Poonam Tewatia and Ghanshyam Pandey.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at # 191 – R Model Town, Panipat, Haryana, India – 132103.
As per the financials filed for FY 2023, the company reported a revenue of ₹40.08 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹16.47 Lakh (net margin -41.1%) and EBITDA of -₹9.36 Lakh (EBITDA margin -23.4%).
For more details, the company can be reached via its website armnpharma.com.
Company details
Contact details
Armn Pharmaceutical India Private Limited's registered office is in Panipat, Haryana. Its website is armnpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address# 191 – R Model Town, Panipat, Haryana, India – 132103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Armn Pharmaceutical India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Armn Pharmaceutical India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Armn Pharmaceutical India Private Limited, buy the company report.
Financials of Armn Pharmaceutical India Private Limited
FY 2023 filings availableArmn Pharmaceutical India Private Limited reported revenue of ₹40.08 Lakh (down 1% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹9.36 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹16.47 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -23.4% | |||
| Net Profit Margin | -41.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Armn Pharmaceutical India Private Limited, buy the company report.
Board of directors of Armn Pharmaceutical India Private Limited
Armn Pharmaceutical India has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Tewatia Also directs: Solenyx Lifescience Private Limited | Director | 25 Oct 2019 | 7 Years 0 Months | Current |
| Ghanshyam Pandey | Director | 25 Oct 2019 | 7 Years 0 Months | Current |
| Monika Also directs: Maven Foods and Feeds Private Limited | Director | 25 Oct 2019 | 7 Years 0 Months | Current |
| Karamvir Singh Malik Also directs: Malik Hatcheries India Private Limited | Director | 25 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Armn Pharmaceutical India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lovyaam Pharma Private Limited | ₹40.27 Lakh (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Steenbrass Pharmaceuticals Private Limited | ₹40.17 Lakh (FY 2015) | -12.0% | Mumbai, Maharashtra, India | |||
| Armn Pharmaceutical India Private Limitedthis company | ₹40.08 Lakh (FY 2023) | -₹16.47 Lakh | -41.1% | -1.0% | Panipat, Haryana, India | |
| Vitabolik Pharmaceuticals Private Limited | ₹39.95 Lakh (FY 2025) | -64.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Armn Pharmaceutical India Private Limited, buy the company report.
Auditor
Armn Pharmaceutical India Private Limited is audited by GUGLANI MITTAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUGLANI MITTAL & CO | FY 2021 | 028483N |
Shareholding
The shareholding of Armn Pharmaceutical India Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Armn Pharmaceutical India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Armn Pharmaceutical India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Armn Pharmaceutical India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Armn Pharmaceutical India has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AASCA8715D2ZJ | Haryana | Active | 08 Feb 2022 |
| 09AASCA8715D1ZE | Uttar Pradesh | Active | 20 Dec 2019 |
To see the full GST registrations and return filing status of Armn Pharmaceutical India Private Limited, buy the company report.
Recent activity
Armn Pharmaceutical India Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Ghanshyam Pandey was appointed as Director on 25 Oct 2019.
Frequently asked questions
Armn Pharmaceutical India is an active private limited company based in Panipat, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 October 2019 (7+ years old) and is registered under CIN U24290HR2019PTC083268.
Armn Pharmaceutical India has 4 current directors:
- Poonam Tewatia - Director
- Ghanshyam Pandey - Director
- Monika - Director
- Karamvir Singh Malik - Director
The latest financial statements of Armn Pharmaceutical India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Armn Pharmaceutical India is 06AASCA8715D2ZJ, registered in Haryana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AASCA8715D1ZE (Uttar Pradesh).
The CIN (Corporate Identification Number) of Armn Pharmaceutical India is U24290HR2019PTC083268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Armn Pharmaceutical India was incorporated on 25 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Armn Pharmaceutical India by revenue are Lovyaam Pharma Private Limited, Steenbrass Pharmaceuticals Private Limited, Vitabolik Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ghanshyam Pandey was appointed as Director on 25 Oct 2019. Karamvir Singh Malik was appointed as Director on 25 Oct 2019. Monika was appointed as Director on 25 Oct 2019. Armn Pharmaceutical India has 4 board changes on record in total.
Armn Pharmaceutical India can be reached through the website armnpharma.com. Its registered office is in Panipat, Haryana, India.
The registered office of Armn Pharmaceutical India is at # 191 – R Model Town, Panipat, Haryana, India – 132103.
Armn Pharmaceutical India operates in the pharma industry, in the drug formulation and development segment.

